Evgueni Parilov
Research Subjects
Research Interests
Evgueni Parilov has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
K. Beeson
Simphotek, Inc. (United States)
6 shared publicationsM. Potasek
Simphotek, Inc. (United States)
6 shared publicationsKarl Beeson
5 shared publicationsMary J. Potasek
Simphotek, Inc. (United States)
5 shared publications- Karl Beeson
Simphotek, Inc., 211 Warren St., Newark, NJ 07103, USA
4 shared publications M. J. Potasek
New York Univ. (USA)
4 shared publications
Latest Publications
- Open Access
Computational Optimization of Irradiance and Fluence for Interstitial Photodynamic Therapy Treatment of Patients with Malignant Central Airway Obstruction
There are no effective treatments for patients with extrinsic malignant central airway obstruction (MCAO). In a recent clinical study, we demonstrated that interstitial photodynamic therapy (I-PDT) is a safe and potentially effective treatment for patients with extrinsic MCAO. In previous preclinical studies, we reported that a minimum light irradiance and fluence should be maintained within a significant volume of the target tumor to obtain an effective PDT response. In this paper, we present a computational approach to personalized treatment planning of light delivery in I-PDT that simultaneously optimizes the delivered irradiance and fluence using finite element method (FEM) solvers of either Comsol Multiphysics® or Dosie™ for light propagation. The FEM simulations were validated with light dosimetry measurements in a solid phantom with tissue-like optical properties. The agreement between the treatment plans generated by two FEMs was tested using typical imaging data from four patients with extrinsic MCAO treated with I-PDT. The concordance correlation coefficient (CCC) and its 95% confidence interval (95% CI) were used to test the agreement between the simulation results and measurements, and between the two FEMs treatment plans. Dosie with CCC = 0.994 (95% CI, 0.953–0.996) and Comsol with CCC = 0.999 (95% CI, 0.985–0.999) showed excellent agreement with light measurements in the phantom. The CCC analysis showed very good agreement between Comsol and Dosie treatment plans for irradiance (95% CI, CCC: 0.996–0.999) and fluence (95% CI, CCC: 0.916–0.987) in using patients’ data. In previous preclinical work, we demonstrated that effective I-PDT is associated with a computed light dose of ≥45 J/cm2 when the irradiance is ≥8.6 mW/cm2 (i.e., the effective rate-based light dose). In this paper, we show how to use Comsol and Dosie packages to optimize rate-based light dose, and we present Dosie’s newly developed domination sub-maps method to improve the planning of the delivery of the effective rate-based light dose. We conclude that image-based treatment planning using Comsol or Dosie FEM-solvers is a valid approach to guide the light dosimetry in I-PDT of patients with MCAO.
Open AccessComputational Optimization of Irradiance and Fluence for Interstitial Photodynamic Therapy Treatment of Patients with Malignant Central Airway Obstruction
There are no effective treatments for patients with extrinsic malignant central airway obstruction (MCAO). In a recent clinical study, we demonstrated that interstitial photodynamic therapy (I-PDT) is a safe and potentially effective treatment for patients with extrinsic MCAO. In previous preclinical studies, we reported that a minimum light irradiance and fluence should be maintained within a significant volume of the target tumor to obtain an effective PDT response. In this paper, we present a computational approach to personalized treatment planning of light delivery in I-PDT that simultaneously optimizes the delivered irradiance and fluence using finite element method (FEM) solvers of either Comsol Multiphysics® or Dosie™ for light propagation. The FEM simulations were validated with light dosimetry measurements in a solid phantom with tissue-like optical properties. The agreement between the treatment plans generated by two FEMs was tested using typical imaging data from four patients with extrinsic MCAO treated with I-PDT. The concordance correlation coefficient (CCC) and its 95% confidence interval (95% CI) were used to test the agreement between the simulation results and measurements, and between the two FEMs treatment plans. Dosie with CCC = 0.994 (95% CI, 0.953–0.996) and Comsol with CCC = 0.999 (95% CI, 0.985–0.999) showed excellent agreement with light measurements in the phantom. The CCC analysis showed very good agreement between Comsol and Dosie treatment plans for irradiance (95% CI, CCC: 0.996–0.999) and fluence (95% CI, CCC: 0.916–0.987) in using patients’ data. In previous preclinical work, we demonstrated that effective I-PDT is associated with a computed light dose of ≥45 J/cm2 when the irradiance is ≥8.6 mW/cm2 (i.e., the effective rate-based light dose). In this paper, we show how to use Comsol and Dosie packages to optimize rate-based light dose, and we present Dosie’s newly developed domination sub-maps method to improve the planning of the delivery of the effective rate-based light dose. We conclude that image-based treatment planning using Comsol or Dosie FEM-solvers is a valid approach to guide the light dosimetry in I-PDT of patients with MCAO.
- 14 March 2023
- Published by SPIE-Intl Soc Optical Eng in Proceedings of SPIE
- Vol. 12359, 5-17
A Monte Carlo simulation for moving light source in intracavity PDT
We developed a simulation method for modeling the light fluence delivery in intracavity Photodynamic Therapy (icav-PDT) for pleural lung cancer using a moving light source. Due to the large surface area of the pleural lung cavity, the light source needs to be moved to deliver a uniform dose around the entire cavity. While multiple fixed detectors are used for dosimetry at a few locations, an accurate simulation of light fluence and fluence rate is still needed for the rest of the cavity. We extended an existing Monte Carlo (MC) based light propagation solver to support moving light sources by densely sampling the continuous light source trajectory and assigning the proper number of photon packages launched along the way. The performance of Simphotek GPU CUDA-based implementation of the method – PEDSy-MC – has been demonstrated on a life-size lung-shaped phantom, custom printed for testing icav-PDT navigation system at the Perlman School of Medicine (PSM) – calculations completed under a minute (for some cases) and within minutes have been achieved. We demonstrate results within a 5% error of the analytic solution for multiple detectors in the phantom. PEDSy-MC is accompanied by a dose-cavity visualization tool that allows real-time inspection of dose values of the treated cavity in 2D and 3D, which will be expanded to ongoing clinical trials at PSM. PSM has developed a technology to measure 8-detectors in a pleural cavity phantom using Photofrin-mediated PDT that has been used during validation.
- 14 March 2023
- Published by SPIE-Intl Soc Optical Eng in Proceedings of SPIE
- Vol. 12359, 5-17
A Monte Carlo simulation for moving light source in intracavity PDT
We developed a simulation method for modeling the light fluence delivery in intracavity Photodynamic Therapy (icav-PDT) for pleural lung cancer using a moving light source. Due to the large surface area of the pleural lung cavity, the light source needs to be moved to deliver a uniform dose around the entire cavity. While multiple fixed detectors are used for dosimetry at a few locations, an accurate simulation of light fluence and fluence rate is still needed for the rest of the cavity. We extended an existing Monte Carlo (MC) based light propagation solver to support moving light sources by densely sampling the continuous light source trajectory and assigning the proper number of photon packages launched along the way. The performance of Simphotek GPU CUDA-based implementation of the method – PEDSy-MC – has been demonstrated on a life-size lung-shaped phantom, custom printed for testing icav-PDT navigation system at the Perlman School of Medicine (PSM) – calculations completed under a minute (for some cases) and within minutes have been achieved. We demonstrate results within a 5% error of the analytic solution for multiple detectors in the phantom. PEDSy-MC is accompanied by a dose-cavity visualization tool that allows real-time inspection of dose values of the treated cavity in 2D and 3D, which will be expanded to ongoing clinical trials at PSM. PSM has developed a technology to measure 8-detectors in a pleural cavity phantom using Photofrin-mediated PDT that has been used during validation.
- Open Access
- 14 March 2023
- Published by SPIE-Intl Soc Optical Eng in Proceedings of SPIE
- Vol. 12359
A real-time IR navigation system for pleural photodynamic therapy with a 3D surface acquisition system
SPIE Digital Library Proceedings
- 14 March 2023
- Published by SPIE-Intl Soc Optical Eng in Proceedings of SPIE
- Vol. 12359
Open AccessA real-time IR navigation system for pleural photodynamic therapy with a 3D surface acquisition system
SPIE Digital Library Proceedings
- Open Access
- 29 September 2022
- Published by Peertechz Publications Private Limited in Global Journal of Cancer Therapy
- Vol. 8 (1) , 021-033
Photodynamic therapy in a pleural cavity using monte carlo simulations with 2D/3D Graphical Visualization
Cancer therapy using Photodynamic Therapy (PDT) has been investigated for some time [1,2] and now it is a growing area of interest in clinical trials [3]. Monte Carlo (MC) simulations were used for early laboratory studies [4,5] for analysis in PDT. Various improvements in the MC method have advanced the field in recent years.
- 29 September 2022
- Published by Peertechz Publications Private Limited in Global Journal of Cancer Therapy
- Vol. 8 (1) , 021-033
Open AccessPhotodynamic therapy in a pleural cavity using monte carlo simulations with 2D/3D Graphical Visualization
Cancer therapy using Photodynamic Therapy (PDT) has been investigated for some time [1,2] and now it is a growing area of interest in clinical trials [3]. Monte Carlo (MC) simulations were used for early laboratory studies [4,5] for analysis in PDT. Various improvements in the MC method have advanced the field in recent years.
- Open Access
- 14 March 2019
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 24 (03) , 035006-9
Validation of combined Monte Carlo and photokinetic simulations for the outcome correlation analysis of benzoporphyrin derivative-mediated photodynamic therapy on mice
Photodynamic therapy (PDT) has been approved by the U.S. Food and Drug Administration for the treatment of esophageal cancer, non-small cell lung cancer, Barrett’s esophagus, and age-related macular degeneration.1 – 6 Two types of PDT killing mechanisms are known to exist when utilizing light-activated photosensitizers (PSs) to generate reactive oxygen species that kill cancer cells. Type I PDT generates superoxide anion () and other secondary oxygen species, such as hydroxyl radicals () or hydrogen peroxide () for treatment.7 Many commonly used PSs are type II. Type II PDT is a complex process7 involving the interactions of the local photosensitizer concentration [PS], the local light fluence rate (intensity or ), and the local oxygen concentration [] in order to produce singlet oxygen (). Furthermore, the local light fluence rate depends on light transmission through intervening tissue having local absorption coefficient, , and local reduced scattering coefficient, . The complexity of the type II PDT process has made monitoring of treatments difficult and unreliable. Many clinical studies have not resulted in optimal treatment due to the lack of reliable dosimetry for singlet oxygen.6- 14 March 2019
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 24 (03) , 035006-9
Open AccessValidation of combined Monte Carlo and photokinetic simulations for the outcome correlation analysis of benzoporphyrin derivative-mediated photodynamic therapy on mice
Photodynamic therapy (PDT) has been approved by the U.S. Food and Drug Administration for the treatment of esophageal cancer, non-small cell lung cancer, Barrett’s esophagus, and age-related macular degeneration.1 – 6 Two types of PDT killing mechanisms are known to exist when utilizing light-activated photosensitizers (PSs) to generate reactive oxygen species that kill cancer cells. Type I PDT generates superoxide anion () and other secondary oxygen species, such as hydroxyl radicals () or hydrogen peroxide () for treatment.7 Many commonly used PSs are type II. Type II PDT is a complex process7 involving the interactions of the local photosensitizer concentration [PS], the local light fluence rate (intensity or ), and the local oxygen concentration [] in order to produce singlet oxygen (). Furthermore, the local light fluence rate depends on light transmission through intervening tissue having local absorption coefficient, , and local reduced scattering coefficient, . The complexity of the type II PDT process has made monitoring of treatments difficult and unreliable. Many clinical studies have not resulted in optimal treatment due to the lack of reliable dosimetry for singlet oxygen.6 - 28 February 2019
- Published by SPIE-Intl Soc Optical Eng
- Vol. 10860, 22
Validation of Dosie combined Monte Carlo and photokinetic simulations for the analysis of HPPH-mediated photodynamic therapy on mice
We compare previously reported 2-(1-hexyloxyethyl)-2-divinyl pyropheophorbide (HPPH) mediated photodynamic therapy (PDT) experimental results for singlet oxygen dose on mice with simulations using a new, integrated, hardware and software device, DosieTM, that calculates light transport and photokinetics for PDT. The two sets of results are consistent and validate the use of the device simulations to predict HPPH-mediated PDT results on mice animal studies.
- 28 February 2019
- Published by SPIE-Intl Soc Optical Eng
- Vol. 10860, 22
Validation of Dosie combined Monte Carlo and photokinetic simulations for the analysis of HPPH-mediated photodynamic therapy on mice
We compare previously reported 2-(1-hexyloxyethyl)-2-divinyl pyropheophorbide (HPPH) mediated photodynamic therapy (PDT) experimental results for singlet oxygen dose on mice with simulations using a new, integrated, hardware and software device, DosieTM, that calculates light transport and photokinetics for PDT. The two sets of results are consistent and validate the use of the device simulations to predict HPPH-mediated PDT results on mice animal studies.
- Open Access
- 5 March 2018
- Published by SPIE-Intl Soc Optical Eng in Proceedings of SPIE
- Vol. 10476, 14
Light fluence dosimetry in lung-simulating cavities
Accurate light dosimery is critical to ensure consistent outcome for pleural photodynamic therapy (pPDT). Ellipsoid shaped cavities with different sizes surrounded by turbid medium are used to simulate the intracavity lung geometry. An isotropic light source is introduced and surrounded by turbid media. Direct measurements of light fluence rate were compared to Monte Carlo simulated values on the surface of the cavities for various optical properties. The primary component of the light was determined by measurements performed in air in the same geometry. The scattered component was found by submerging the air-filled cavity in scattering media (Intralipid) and absorbent media (ink). The light source was located centrally with the azimuthal angle, but placed in two locations (vertically centered and 2 cm below the center) for measurements. Light fluence rate was measured using isotropic detectors placed at various angles on the ellipsoid surface. The measurements and simulations show that the scattered dose is uniform along the surface of the intracavity ellipsoid geometries in turbid media. One can express the light fluence rate empirically as φ =4S/As*Rd/(1- Rd), where Rd is the diffuse reflectance, As is the surface area, and S is the source power. The measurements agree with this empirical formula to within an uncertainty of 10% for the range of optical properties studied. GPU voxel-based Monte-Carlo simulation is performed to compare with measured results. This empirical formula can be applied to arbitrary geometries, such as the pleural or intraperitoneal cavity.
- 5 March 2018
- Published by SPIE-Intl Soc Optical Eng in Proceedings of SPIE
- Vol. 10476, 14
Open AccessLight fluence dosimetry in lung-simulating cavities
Accurate light dosimery is critical to ensure consistent outcome for pleural photodynamic therapy (pPDT). Ellipsoid shaped cavities with different sizes surrounded by turbid medium are used to simulate the intracavity lung geometry. An isotropic light source is introduced and surrounded by turbid media. Direct measurements of light fluence rate were compared to Monte Carlo simulated values on the surface of the cavities for various optical properties. The primary component of the light was determined by measurements performed in air in the same geometry. The scattered component was found by submerging the air-filled cavity in scattering media (Intralipid) and absorbent media (ink). The light source was located centrally with the azimuthal angle, but placed in two locations (vertically centered and 2 cm below the center) for measurements. Light fluence rate was measured using isotropic detectors placed at various angles on the ellipsoid surface. The measurements and simulations show that the scattered dose is uniform along the surface of the intracavity ellipsoid geometries in turbid media. One can express the light fluence rate empirically as φ =4S/As*Rd/(1- Rd), where Rd is the diffuse reflectance, As is the surface area, and S is the source power. The measurements agree with this empirical formula to within an uncertainty of 10% for the range of optical properties studied. GPU voxel-based Monte-Carlo simulation is performed to compare with measured results. This empirical formula can be applied to arbitrary geometries, such as the pleural or intraperitoneal cavity.
- 8 February 2017
- Published by SPIE-Intl Soc Optical Eng
- Vol. 10047, 100470R-100470R-10
Overview of computational simulations for PDT treatments based on optimal choice of singlet oxygen
- 8 February 2017
- Published by SPIE-Intl Soc Optical Eng
- Vol. 10047, 100470R-100470R-10
Overview of computational simulations for PDT treatments based on optimal choice of singlet oxygen
- Open Access
Interstitial Photodynamic Therapy—A Focused Review
Multiple clinical studies have shown that interstitial photodynamic therapy (I-PDT) is a promising modality in the treatment of locally-advanced cancerous tumors. However, the utilization of I-PDT has been limited to several centers. The objective of this focused review is to highlight the different approaches employed to administer I-PDT with photosensitizers that are either approved or in clinical studies for the treatment of prostate cancer, pancreatic cancer, head and neck cancer, and brain cancer. Our review suggests that I-PDT is a promising treatment in patients with large-volume or thick tumors. Image-based treatment planning and real-time dosimetry are required to optimize and further advance the utilization of I-PDT. In addition, pre- and post-imaging using computed tomography (CT) with contrast may be utilized to assess the response.
Open AccessInterstitial Photodynamic Therapy—A Focused Review
Multiple clinical studies have shown that interstitial photodynamic therapy (I-PDT) is a promising modality in the treatment of locally-advanced cancerous tumors. However, the utilization of I-PDT has been limited to several centers. The objective of this focused review is to highlight the different approaches employed to administer I-PDT with photosensitizers that are either approved or in clinical studies for the treatment of prostate cancer, pancreatic cancer, head and neck cancer, and brain cancer. Our review suggests that I-PDT is a promising treatment in patients with large-volume or thick tumors. Image-based treatment planning and real-time dosimetry are required to optimize and further advance the utilization of I-PDT. In addition, pre- and post-imaging using computed tomography (CT) with contrast may be utilized to assess the response.
- 13 March 2015
- Published by SPIE-Intl Soc Optical Eng
- Vol. 9369, 93690V
Optimizing experimental conditions for stimulated emission depletion microscopy in biophotonics
Using a novel numerical method we show how to optimize the resolution enhancement of stimulated emission depletion (STED) by simulating the entire process including the absorption, overlapping multiple beams and stimulated emission. We provide calculations showing that for fixed donut pulse energy, a longer donut pulse length can result in greater resolution enhancement than a shorter donut pulse length. These results show how it is possible to use our simulations to design the best experimental conditions for STED resolution enhancement and illustrate the importance of having a software program that includes both multiple beams and stimulated emission.
- 13 March 2015
- Published by SPIE-Intl Soc Optical Eng
- Vol. 9369, 93690V
Optimizing experimental conditions for stimulated emission depletion microscopy in biophotonics
Using a novel numerical method we show how to optimize the resolution enhancement of stimulated emission depletion (STED) by simulating the entire process including the absorption, overlapping multiple beams and stimulated emission. We provide calculations showing that for fixed donut pulse energy, a longer donut pulse length can result in greater resolution enhancement than a shorter donut pulse length. These results show how it is possible to use our simulations to design the best experimental conditions for STED resolution enhancement and illustrate the importance of having a software program that includes both multiple beams and stimulated emission.